Anika Therapeutics (AKP.F) Q3 2024 Earnings

8AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.21
-0.09
0.03
0.16

Details

Expected EPS
0.06106763867
Actual EPS
0.15572170000000002
Surprise EPS
0.09
Surprise Percent
+155%

Description

Anika Therapeutics (AKP.F) has reported earnings of 0.15572170000000002 per share for Q3 2024.

0 Comments

Share your thoughts